← Назад

Lafora disease

ORPHA:501DiseaseAutosomal recessiveAdolescent, Childhood

Ассоциированные гены (2)

EPM2A
EPM2A glucan phosphatase, laforin
Disease-causing germline mutation(s) (loss of function) in
OMIM: 607566
NHLRC1
NHL repeat containing E3 ubiquitin protein ligase 1
Disease-causing germline mutation(s) (loss of function) in
OMIM: 608072

Фенотипы (35)

Облигатный (100%)1
HP:0100318Lafora bodies
Очень частый (80–99%)1
HP:0001250Seizure
Частый (30–79%)19
HP:0000712Emotional lability
HP:0000716Depression
HP:0000726Dementia
HP:0001251Ataxia
HP:0001257Spasticity
HP:0001260Dysarthria
HP:0001268Mental deterioration
HP:0001288Gait disturbance
HP:0001289Confusion
HP:0001312Giant somatosensory evoked potentials
HP:0002100Recurrent aspiration pneumonia
HP:0002123Generalized myoclonic seizure
HP:0002133Status epilepticus
HP:0002315Headache
HP:0002367Visual hallucinations
HP:0002521Hypsarrhythmia
HP:0002540Inability to walk
HP:0025357Erratic myoclonus
HP:0040288Nasogastric tube feeding
Периодический (5–29%)14
HP:0001336Myoclonus
HP:0001399Hepatic failure
HP:0002069Bilateral tonic-clonic seizure
HP:0002121Generalized non-motor (absence) seizure
HP:0002360Sleep abnormality
HP:0002384Focal impaired awareness seizure
HP:0007270Atypical absence seizure
HP:0007334Bilateral tonic-clonic seizure with focal onset
HP:0007359Focal-onset seizure
HP:0007537Severe photosensitivity
HP:0010819Atonic seizure
HP:0011165Focal sensory seizure with visual features
HP:0012444Brain atrophy
HP:0031358Vegetative state

Эпидемиология (4)

Point prevalence
1-9 / 1 000 000
France
Point prevalence
1-9 / 1 000 000
Europe
Cases/families
Worldwide
Point prevalence
1-9 / 1 000 000
Worldwide

Лекарства и терапия

Источник: Open Targets Platform (в реальном времени)

Клинические исследования

Источник: ClinicalTrials.gov (в реальном времени)

Внешние ресурсы